1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Immunogenicity and Safety of 2 Doses of Avian Influenza A (H5N1) Vaccine Administered 3 vs. 8 Weeks ApartInfections, RNA Virus Infections, avian influenza, bird disease, influenza, non-human animal disease, viral infectious diseaseActive, not recruitingPhase 42026-01-16NCT07275060